Biolife Solutions Inc (BLFS) insider trading
Every open-market stock purchase and sale by Biolife Solutions Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Company insiders sold $34M over the last 12 months (30 sales), with no open-market buys.
- Last company insider buy: Casdin Partners Master Fund L.P. (10%+ shareholder), $10.4M, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $34M (30 sales). Last close $38.61 on Oct 5, 2026.
Recent BLFS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 6, 2026 | Roderick De Greef (CEO) | Sold (not open market) | $14.1M |
| Oct 6, 2026 | Troy Wichterman (CFO) | Sold (not open market) | $3.7M |
| Oct 6, 2026 | Sean Werner (CTO) | Sold (not open market) | $2.8M |
| Oct 6, 2026 | Aby J. Mathew (C-suite exec) | Sold (not open market) | $2.7M |
| Oct 6, 2026 | Todd Berard (C-suite exec) | Sold (not open market) | $1.8M |
| Oct 6, 2026 | Roderick De Greef (CEO) | Bought (not open market) | — |
| Oct 6, 2026 | Aby J. Mathew (C-suite exec) | Bought (not open market) | — |
| Oct 6, 2026 | Timothy L. Moore (Insider) | Sold (not open market) | — |
| Oct 6, 2026 | Troy Wichterman (CFO) | Bought (not open market) | — |
| Oct 6, 2026 | Anthony Hunt (Insider) | Sold (not open market) | — |
| Oct 6, 2026 | Rachel Ellingson (Insider) | Sold (not open market) | — |
| Oct 6, 2026 | Joydeep Goswami (Insider) | Sold (not open market) | — |
| Oct 6, 2026 | Todd Berard (C-suite exec) | Bought (not open market) | — |
| Oct 6, 2026 | Troy Wichterman (CFO) | Sold (not open market) | — |
| Oct 6, 2026 | Todd Berard (C-suite exec) | Sold (not open market) | — |
| Oct 6, 2026 | Sean Werner (CTO) | Sold (not open market) | — |
| Oct 6, 2026 | Sean Werner (CTO) | Bought (not open market) | — |
| Oct 6, 2026 | Roderick De Greef (CEO) | Bought (not open market) | — |
| Oct 6, 2026 | Amy DuRoss (Insider) | Sold (not open market) | — |
| Oct 6, 2026 | Aby J. Mathew (C-suite exec) | Bought (not open market) | — |
| Oct 6, 2026 | Sean Werner (CTO) | Bought (not open market) | — |
| Oct 6, 2026 | Aby J. Mathew (C-suite exec) | Sold (not open market) | — |
| Oct 6, 2026 | Catherine Coste (Insider) | Sold (not open market) | — |
| Oct 6, 2026 | Troy Wichterman (CFO) | Bought (not open market) | — |
| Oct 6, 2026 | Roderick De Greef (CEO) | Sold (not open market) | — |
Who's trading BLFS
- Troy Wichterman, CFO: sold $851K (5 sales), last Oct 6, 2026
- Todd Berard, C-suite exec: sold $34.5K (4 sales), last Oct 6, 2026
- Rachel Ellingson, Director: other filings, last Oct 6, 2026
- Joydeep Goswami, Director: other filings, last Oct 6, 2026
- Anthony Hunt, Director: other filings, last Oct 6, 2026
- Timothy L. Moore, Director: other filings, last Oct 6, 2026
- Aby J. Mathew, C-suite exec: sold $51.3K (4 sales), last Oct 6, 2026
- Sean Werner, CTO: sold $5.2K (2 sales), last Oct 6, 2026
- Catherine Coste, Director: other filings, last Oct 6, 2026
- Roderick De Greef, CEO: sold $2.6M (3 sales), last Oct 6, 2026
- Amy DuRoss, Director: sold $306K (6 sales), last Oct 6, 2026
- Casdin Partners Master Fund L.P., 10% owner: sold $28.1M (3 sales), last May 21, 2026
- Karen A. Foster, Officer: sold $2.1M (7 sales), last Mar 23, 2026
- Sarah Aebersold, Officer: sold $39.8K (5 sales), last Mar 19, 2026
Get free alerts when an insider at Biolife Solutions Inc files a new trade →